With AWS on board, ElevateBio says that it can design high-level CRISPR proteins with improved therapeutic potential both for partners and internal pipeline development. The company’s technology ...

The medical promise of CRISPR gene editing can be seen most easily in current research on oral cancer, which affects more than 50,000 Americans every year. An increasing challenge in the treatment ...

Learn about Brink Therapeutics as it raises $4 million to go beyond CRISPR with engineered recombinases in CAR T therapy.

Gene editing technologies have cemented their place as a valued method in the biological toolkit used by researchers around the globe.

13. WASHINGTON — Keith Joung knows better than a lot of people what, exactly, it might require to prove to regulators and patients that CRISPR could be safely used to alter the genome of a human ...

CRISPR Therapeutics won its first regulatory approval a little over a year ago, and has compelling candidates in the pipeline. Of course, Vertex's success didn't happen overnight -- and the ...

The study, published in Nucleic Acids Research, introduces BLU-VIPR, a method that allows researchers to control the gene-editing tool CRISPR using light. This innovation could significantly ...

A research team has developed an advanced delivery system that transports gene-editing tools based on the CRISPR/Cas9 gene-editing system into living cells with significantly greater efficiency than ...

The Asia Pacific region is poised for a significant surge in the CRISPR gene editing market, projected to expand by 28.6% annually over the period of 2022-2031. With a total addressable market cap ...